Westminster Health Forum

The future of the life sciences sector in the UK - funding, regulation and the impact of Brexit

Wednesday, 1st March 2017

Royal Society, 6-9 Carlton House Terrace, London SW1Y 5AG


This timely seminar focuses on the future of the life sciences industry in the UK.

It is scheduled as the Department for Business, Energy and Industrial Strategy consults on the Industrial Strategy, which sets out an early life sciences sector deal - and in the context of uncertainty for the sector following the UK’s vote to leave the European Union.

Delegates will consider proposals from the UK EU Life Sciences Transition Programme on managing the transition and how this presents challenges and opportunities for industry, with a particular focus on regulation - with priorities for the MHRA and the European Medicines Agency, as well as the next steps for research and development.

Further sessions focus on clinical trials and encouraging patient participation, in light of the launch of the European Commission’s new Clinical Trial Regulation in 2018; key issues for workforce development - including skills, recruitment and retention - as well as the next steps for encouraging innovation in the NHS after the publication of the Accelerated Access Review.

Guest of Honour

Dr Ian Hudson

Chief Executive, MHRA and Member (UK), Management Board, European Medicines Agency

Guest of Honour

Dr Ian Hudson

Chief Executive, MHRA and Member (UK), Management Board, European Medicines Agency


Daniel Zeichner MP

Vice Chair, All-Party Parliamentary Group for Life Sciences


Professor Carole Longson

Director, Centre for Health Technology Evaluation, NICE

Aisling Burnand

Chief Executive, Association of Medical Research Charities

Doris-Ann Williams

Chief Executive, British In Vitro Diagnostics Association

Nishan Sunthares

Chief Operating Officer, ABHI

Dr Rebecca Lumsden

Head of Science Policy, ABPI

Joanna Woolf

Chief Executive, Cogent Skills

Professor Sir Robert Lechler

President, The Academy of Medical Sciences and Executive Director, King’s Health Partners

Dr John Williams

Managing Director, Birmingham Health Partners